2019 Victorian Cancer Agency Funding Round – now open
VCA’s funding schemes are now open and will close at 5.00 pm on 25 September 2019. Click on the link below for more information.
ResearcHer June 2019 edition
Get updates on ANZGOG’s latest research, awareness and fundraising activities.
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study
New Position Statement – Cancer Australia
Cancer Australia has released an updated Position Statement – Testing for ovarian cancer in asymptomatic women.
2019 ASM – Round-up
The 2019 Annual Scientific Meeting took place at the Sofitel Sydney Wentworth from 20th to 23rd March, inspired by the theme ‘Radical Treatments for Gynaecological Cancers: hope or hype’. With 260 delegates, this was the largest ANZGOG ASM to date.
National recognition for ANZGOG’s Clare Scott and Duncan McPherson
ANZGOG’s Professor Clare Scott and Mr Duncan McPherson have achieved national recognition for outstanding contributions to improving outcomes in gynaecological cancer.
Dr Mahesh Iddawela is making sure all patients in Gippsland get access to quality care and clinical trials.
Dr Iddawela leads the Gippsland Cancer Survivorship Program and is a member of ANZGOG’s Endometrial Tumour Type Working Group.
New comic book helps kids understand ovarian cancer
A new comic book “Understanding Ovarian Cancer” is helping children and young people understand ovarian cancer. Available for free online and in hard copy.
STATEC trial: Defining best practice in endometrial cancer
Cancer of the womb (also referred to as endometrial cancer or uterine cancer) is the most common gynaecological cancer in Australia.
Mary Anne shares her family’s inspirational story of ovarian cancer
Too many families experience the tragedy that ovarian cancer can bring. Mary Anne’s family story is not unique, however, it is amazingly inspirational.
Ovarian cancer survivor and mother: Veronica, shares her story
Most women diagnosed with ovarian cancer will not survive five years from diagnosis. Veronica shares her story as an ovarian cancer survivor and mother.
ANZGOG 2018: Challenges in Precision Gynaecological Cancer in a Molecular Era
Published in Oncology News on 7 May, 2018: four members of ANZGOG share their highlights from the ANZGOG Annual Scientific Meeting.
Better treatment for endometrial cancer: PORTEC 3
The PORTEC 3 endometrial cancer trial has been ten years in the making but now provides insights into better treatments. Better treatments improve lives.
ANZGOG Board appoints new Chair: Associate Professor Philip Beale
Associate Professor Philip Beale is appointed by the ANZGOG Board as Chair of ANZGOG from 30 March 2018. He has been a member of ANZGOG since inception.
Survivors Teaching Students: Caitlin
Caitlin is a volunteer Presenter with ANZGOG’s Survivors Teaching Students, an ovarian cancer awareness program. Find out why she volunteered and what motivates her as a Presenter.
Dr Michelle Wilson on thinking outside the box in ovarian cancer
Michelle Wilson believes that thinking outside the box is one of the best skills clinicians can have for their patients. She was awarded a Fund for New Research grant in 2016 for her ovarian cancer study NEO.
Progress in the prevention and treatment of cervical cancer
New evidence about the role of human papilloma virus (HPV) in the development of cervical cancer and new technologies to detect the virus have led to a new National Cervical Screening Program.
ANZGOG Preceptorship in ovarian cancer 2017
ANZGOG’s inaugural Preceptorship in ovarian cancer provided trainees and students a review of the most important advances in ovarian cancer in recent times.
Improving treatment practices in cervical cancer: EXCISE study
Dr Paul Cohen received funding to run a pilot study in cervical cancer through the ANZGOG Fund for New Research. The study is called EXCISE and is comparing two treatments for removing (or excising) adenocarcinoma in situ (AIS) lesions from the cervix.
Save the Box gets people talking
In 2018 Save the Box achieved a potential reach of more than 150 million people through public, news, and social media.
Australian of the Year Karen Livingstone Nominated for 2018
Ms Karen Livingstone, ANZGOG Board member, has been selected as a Victorian Finalist for the Australian of the Year Awards.
Trial results: Paragon
Paragon is a group of 7 trials involving women with potentially hormone-responsive cancers of the uterus and ovaries. The trials are helping researchers answer important questions about the role of antiestrogens to treat these cancers. The results could change the way some cancers are treated in the future.
CREST Newsletter: September 2017
The Cancer Research Economics Support Team (CREST) Newsletter September edition contains articles on health economics and cancer care, as well as updates from clinical trials groups.
Dr Paul Cohen, Consultant Gynaecologist and Clinical Researcher
Perth’s Dr Paul Cohen receives grant to run a pilot study on precancerous changes of the cervix.
Ovarian cancer diagnosis turns power mum into cancer patient
Cath was a dedicated stay at home mum who left university in her 20s to support and bring up her three sons. Suddenly last year her world came crashing down when she was diagnosed with advanced ovarian cancer.
Having cancer changed my life for the better
Louise Mitchell used to weigh 165kg and was too heavy to have the surgery she needed to save her life. Now, her whole world has changed.
Gynaecological cancer stats grim as women continue to avoid regular testing
GO and get tested. That’s the best advice to fight gynaecological cancer from one of south west Sydney’s top specialists, Dr Diana Adams.
Gynaecological cancer survivor: “I might be little but I’m a fighter”
When Amelia was just two, her parents Megan, 36, and Benn, 35, noticed a lump on her labia while changing her nappy. Gynaecologist Dr Sonia Grover at the Royal Melbourne Children’s Hospital diagnosed Amelia with rhabdomyosarcoma-volvo – a gynaecological cancer affecting just one in 250,000 people in Australasia.